Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for actavis pharma company in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (16)
Results: 1-16 | Export
  1. Actavis Pharma Company
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President, Canada & Latin America
    Registration: 16 of 16 (2016-01-18 to 2016-09-02)
    Posted: 2016-01-19
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  2. Actavis Pharma Company
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President, Canada & Latin America
    Registration: 15 of 16 (2015-01-16 to 2016-01-18)
    Posted: 2015-01-19
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  3. Actavis Pharma Company
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President, Canada & Latin America
    Registration: 14 of 16 (2014-05-22 to 2015-01-16)
    Posted: 2014-05-23
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  4. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President, Canada & Latin America
    Registration: 13 of 16 (2013-09-16 to 2014-05-22)
    Posted: 2013-09-18
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  5. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 12 of 16 (2013-01-17 to 2013-09-16)
    Posted: 2013-01-18
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  6. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 11 of 16 (2012-11-16 to 2013-01-17)
    Posted: 2012-11-16
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  7. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 10 of 16 (2012-07-03 to 2012-11-16)
    Posted: 2012-07-03
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  8. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 9 of 16 (2012-04-18 to 2012-07-03)
    Posted: 2012-04-18
    Subject matter details: 8
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  9. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 8 of 16 (2012-02-27 to 2012-04-18)
    Posted: 2012-02-27
    Subject matter details: 8
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  10. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 7 of 16 (2011-09-14 to 2012-02-27)
    Posted: 2011-09-14
    Subject matter details: 8
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  11. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Jean-Guy Goulet, President
    Registration: 6 of 16 (2011-04-11 to 2011-09-14)
    Posted: 2011-06-20
    Subject matter details: 8
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  12. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Terry Fretz, Chief Executive Officer
    Registration: 5 of 16 (2011-02-16 to 2011-04-11)
    Posted: 2011-02-17
    Subject matter details: 8
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  13. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Terry Fretz, Chief Executive Officer
    Registration: 4 of 16 (2010-06-18 to 2011-02-16)
    Posted: 2010-07-14
    Subject matter details: 8
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  14. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Ian Jacobson, Chief Executive Officer
    Registration: 3 of 16 (2010-03-17 to 2010-06-18)
    Posted: 2010-03-18
    Subject matter details: 8
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  15. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Ian Jacobson, Chief Executive Officer
    Registration: 2 of 16 (2009-09-16 to 2010-03-17)
    Posted: 2009-09-16
    Subject matter details: 8
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  16. Cobalt Pharmaceuticals Inc.
    Type: In-house Corporation
    Responsible officer: Ian Jacobson, Chief Executive Officer
    Registration: 1 of 16 (2009-01-02 to 2009-09-16)
    Posted: 2009-02-24
    Subject matter details: 8
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
Monthly communication reports (37)
Results: 1-37 | Export
  1. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2016-02-11
    Posted: 2016-03-09
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  2. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2013-01-17
    Posted: 2013-02-15
    Designated public office holders:
    • Ted Opitz, Member of Parliament | House of Commons
    • Terence Young, Member of Parliament | House of Commons
    • Stella Ambler, Member of parliament | House of Commons
    • Bernard Trottier, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • International Trade
    • Health
      •
  3. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-10-02
    Posted: 2012-11-16
    Designated public office holders:
    • Nancy Ruth, Senator | Senate of Canada
    • Devinder Shorey, Member of Parliament | House of Commons
    • Stella Ambler, Member of Parliement | House of Commons
    • Bernard Trottier, Member of Parliament | House of Commons
    • Corneliu Chisu, Member of Parliament | House of Commons
    • Phil McColeman, Member of Parliament | House of Commons
    • Patrick Brown, Member of Parliament | House of Commons
    • Rob Merrifield, Member of Parliement | House of Commons
    • Randy Hoback, Member of Parliement | House of Commons
    • Chungsen Leung, Member of Parliament | House of Commons
    • Ted Opitz, Member of Parliement | House of Commons
    • Rick Norlock, Member of Parliement | House of Commons
    • Terence Young, Member of Parliement | House of Commons
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • International Trade
      •
  4. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-04-26
    Posted: 2012-05-14
    Designated public office holders:
    • Ron Cannan, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Industry
    • International Trade
      •
  5. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-04-26
    Posted: 2012-05-14
    Designated public office holders:
    • Rob Merrifield, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
    • Intellectual Property
    • Industry
      •
  6. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-04-26
    Posted: 2012-05-14
    Designated public office holders:
    • Bernard Trottier, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
    • Intellectual Property
    • Industry
      •
  7. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-04-26
    Posted: 2012-05-14
    Designated public office holders:
    • Kellie Leitch, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • International Trade
      •
  8. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-04-16
    Posted: 2012-05-15
    Designated public office holders:
    • Eve Adams, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
      •
  9. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-03-19
    Posted: 2012-03-22
    Designated public office holders:
    • Cornelius Chisu, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
    • Industry
    • Intellectual Property
      •
  10. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-03-02
    Posted: 2012-04-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Industry
      •
  11. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-02-24
    Posted: 2012-03-16
    Designated public office holders:
    • Bal Gosal, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
    • Industry
    • Health
      •
  12. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-02-03
    Posted: 2012-02-03
    Designated public office holders:
    • Joe Oliver, Member of Parliement | House of Commons
    Subject matters:
    • Health
    • International Trade
      •
  13. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-02-02
    Posted: 2012-03-22
    Designated public office holders:
    • Sean O'Leary, Policy Advisor, Office of the Minister | Industry Canada
    • Christian Paradis, Minister of Industry | Industry Canada
    Subject matters:
    • Intellectual Property
    • Industry
    • International Trade
      •
  14. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-01-27
    Posted: 2012-02-16
    Designated public office holders:
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    • Ted Opitz, Member of Parliament | House of Commons
    • Julian Fantino, Member of Parliment | House of Commons
    Subject matters:
    • International Trade
    • Industry
      •
  15. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-01-25
    Posted: 2012-02-16
    Designated public office holders:
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    • Brad Butt, Member of Parliament | House of Commons
    • Stella Amber, Member of Parliament | House of Commons
    • Bal Gosal, Minister of State (Sport) | Canadian Heritage (PCH)
    Subject matters:
    • Health
    • International Trade
    • Industry
    • Intellectual Property
      •
  16. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-01-12
    Posted: 2012-02-16
    Designated public office holders:
    • Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
    • John Connell, Associate Assistant Deputy Minister | Industry Canada
    • Simon Kennedy, Senior Associate Deputy Minister | Industry Canada
    Subject matters:
    • Industry
    • Intellectual Property
    • International Trade
      •
  17. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2012-01-10
    Posted: 2012-01-23
    Designated public office holders:
    • Terence Young, Member of parliament | House of Commons
    Subject matters:
    • International Trade
    • Industry
      •
  18. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-12-19
    Posted: 2011-12-19
    Designated public office holders:
    • Chris Alexander, MP, Ajax-Pickering | House of Commons
    Subject matters:
    • International Trade
      •
  19. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-12-09
    Posted: 2011-12-12
    Designated public office holders:
    • Mark Adler, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
      •
  20. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-11-18
    Posted: 2011-11-22
    Designated public office holders:
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • International Trade
      •
  21. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-11-10
    Posted: 2011-11-17
    Designated public office holders:
    • Kyle Seeback, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
      •
  22. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-11-09
    Posted: 2011-11-17
    Designated public office holders:
    • Lois Brown, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • International Trade
      •
  23. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-10-12
    Posted: 2011-10-18
    Designated public office holders:
    • Brad Butt, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Industry
    • International Trade
    • Health
      •
  24. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-08-24
    Posted: 2011-09-14
    Designated public office holders:
    • Brad Butt, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • International Trade
      •
  25. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-03-08
    Posted: 2011-04-16
    Designated public office holders:
    • Blaine Calkins, Member of Parliament | House of Commons
    • Gerry Breitkreuz, Member of Parliament | House of Commons
    • Andrew Saxton, Member of Parliament | House of Commons
    • Ron Cannan, Member of Parliament | House of Commons
    • Leon Benoit, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Intellectual Property
    • International Trade
    • Industry
      •
  26. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-02-15
    Posted: 2011-03-16
    Designated public office holders:
    • Bryon Wilfert, Member of Parliament | House of Commons
    • Judy Sgro, Member of Parliament | House of Commons
    • Bonnie Crombie, Member of Parliament | House of Commons
    • Kirsty Duncan, Member of Parliament | House of Commons
    • Derek Lee, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • International Trade
    • Industry
    • Health
      •
  27. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2011-02-15
    Posted: 2011-03-16
    Designated public office holders:
    • Alan Tonks, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Industry
    • Health
    • International Trade
      •
  28. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-10-19
    Posted: 2010-11-16
    Designated public office holders:
    • Bonnie Crombie, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Intellectual Property
    • Internal Trade
    • Health
      •
  29. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-10-19
    Posted: 2010-11-16
    Designated public office holders:
    • Tim Uppal, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Health
    • International Trade
    • Industry
      •
  30. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-10-19
    Posted: 2010-11-16
    Designated public office holders:
    • Kelvin Ogilvie, Senator | Senate of Canada
    Subject matters:
    • International Trade
    • Health
    • Industry
    • Intellectual Property
      •
  31. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-10-19
    Posted: 2010-11-16
    Designated public office holders:
    • Lee Richardson, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Industry
    • International Trade
    • Health
      •
  32. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-10-19
    Posted: 2010-11-16
    Designated public office holders:
    • Patrick Brown, Member of Parliament | House of Commons
    Subject matters:
    • International Trade
    • Intellectual Property
    • Industry
    • Health
      •
  33. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2010-04-27
    Posted: 2010-05-25
    Designated public office holders:
    • Elie Salibi, Policy Advisor, Office of the Minister | Industry Canada
    Subject matters:
    • Industry
    • Intellectual Property
      •
  34. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2009-10-27
    Posted: 2009-11-16
    Designated public office holders:
    • Elie Salibi, Policy Advisor, office of the MInister | Industry Canada
    Subject matters:
    • Intellectual Property
    • Industry
      •
  35. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2009-05-05
    Posted: 2009-06-16
    Designated public office holders:
    • Andrew Wallace, Policy Advisor, Industry and Finance | Prime Minister's Office (PMO)
    Subject matters:
    • Industry
    • PMPRB
      •
  36. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2009-01-14
    Posted: 2009-02-24
    Designated public office holders:
    • Leah Canning, Policy Advisor, Office of the Minister | Health Canada (HC)
    • Leona Aglukkaq, Minister of Health | Health Canada (HC)
    • Meena Ballantyne, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  37. Actavis Pharma Company
    Type: In-house Corporation
    Occurred: 2009-01-14
    Posted: 2009-02-24
    Designated public office holders:
    • Richard Dicerni, Deputy Minister | Industry Canada
    Subject matters:
    • Health
    • Intellectual Property
      •
Date Modified: